Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2021 Sterile Drug Market Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
More+
Staffing
Media Kit
Press Releases
2815 Articles Available
1
118
Can't find what you're looking for? Try our
advanced search
.
Genentech Launches Oncology Clinical Trial Diversity Alliance
PR-M06-21-031
Expansion
Olon Announces a New Highly Potent API Expansion in Its Rodano Site
PR-M06-21-030
M&A
Paramit Corporation Announces Acquisition by The Tecan Group
PR-M06-21-029
COVID-19 Vaccine
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
PR-M06-21-028
COVID-19 Testing
Roche Obtains CE Mark for the SARS-CoV-2 Antigen Self Test Nasal Allowing for Rapid Self Testing of COVID-19 At Home
PR-M06-21-027
DNA Purification
Biotage Launches New Automated Platform for Plasmid DNA Purification
PR-M06-21-026
Clinical Data
X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021
PR-M06-21-025
Partnership
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
PR-M06-21-024
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder
PR-M06-21-023
Financing
Kahr Announces $46.5 Million Financing to Advance Its Multifunctional Immunotherapeutic Pipeline
PR-M06-21-021
Oral Therapy
Novartis Investigational Oral Therapy Iptacopan (Lnp023) Shows Benefit as Monotherapy in Treatment-Naïve Patients with Rare and Life-threatening Blood Disorder Paroxysmal Nocturnal Hemoglobinuria
PR-M06-21-022
COVID-19
Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities
PR-M06-21-020
Facility Acquisition
TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom
PR-M06-21-019
Cancer Research
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
PR-M06-21-018
Anniversary
Alconox Inc. Announced Its 75th Anniversary as an Internationally Distributed Manufacturer of Critical Cleaning Detergents
PR-M06-21-017
Diagnostic
GRAIL Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test
PR-M06-21-016
Clinical Trials
Yourway's Major Expansion to Support Clinical Trial Needs
PTV-06-21-CL-002
FDA Approval
FDA Grants Accelerated Approval for Aduhelm™ as the First and Only Alzheimer’s Disease Treatment to Address a Defining Pathology of the Disease
PR-M06-21-015
Leadership
Alan Jones Returns to CRB as Vice President of Business Development
PR-M06-21-014
Series A Financing
RheaVita Closes EUR 2.5 million Series A Financing Co-Led by Novalis Biotech Acceleration and PMV
PR-M06-21-011
Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra®
PR-M06-21-010
Licensing
Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases
PR-M06-21-009
FDA Approval
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Zeposia® (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis
PR-M06-21-008
Rebranding
BIOVECTRA Inc. Looks Inward for New Brand: It’s All About Care
PR-M06-21-013
1
118
»
